AI Now offers lessons on transparency, other aspects of an ‘FDA for AI’

Researchers at the AI Now Institute have produced a comprehensive report examining the structure and function of the Food and Drug Administration as a potential template for establishing an agency dedicated to regulating artificial intelligence technology, with notable takeaways for addressing issues like transparency.

The report out this month comes amid frequent discussion of the need for a central regulator while existing laws across various sectors already apply to the development and deployment of the technology. It was assembled...